Full name
ANDAR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA W ŁAŃCUCIE
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
68.32.Z - Other real estate activities on behalf of third parties
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.C - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -12,8 | -2,4 | -1,1 | 53,8 |
EBITDA | -12,8 | -2,4 | -1,1 | 53,8 |
Short time liabilities | 7,2 | 9,3 | 10,4 | 11,9 |
Equity capital | -6,8 | -9,2 | -10,3 | -12 |
Operating profit (EBIT) | -12,8 | -2,4 | -1,1 | 53,8 |
Assets | 0,3 | 0,1 | 0,1 | 0 |
Net profit (loss) | -12,8 | -2,4 | -1,1 | 53,8 |
Cash | 0,3 | 0,1 | 0,1 | 0 |
Liabilities and provisions for liabilities | 7,2 | 9,3 | 10,4 | 11,9 |
Net income from sale | 19,9 | 0 | 0 | 0 |
Working assets | 0,3 | 0,1 | 0,1 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 187,9 | 26 | 10,7 | -15,3 |
Equity capital to total assets | -2077,8 | -12 467,8 | -13 963,2 | -1495,4 |
Gross profit margin | -64,5 | -3,8 | ||
EBITDA Margin | -64,4 | -3,7 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 131 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.045917853713035583 | 0.007956846617162228 | 0.007110759150236845 | 0 |
Net dept to EBITDA | -0.5335161685943604 | -3.849215030670166 | -9.337413787841797 | -5,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane